Corporate VP Business Development, Novo Nordisk

SVP, Head Global BD & Alliance Management, Merck

VP, Head of Global Neuroscience & Rare Disease Partnering, Ipsen

VP, Scientific Innovation, Oncology, Johnson & Johnson Innovation

SVP Business Development, Oncology & Haematology, Bristol Myers Squibb

Senior Director, Early Innovation Partnering Immunology, EMEA, Johnson & Johnson Innovation

Senior Director, Oncology Worldwide Business Development, GSK

Director, Enterprise Innovation, AbbVie and President-Elect, Women in Bio (WIB)

Assistant General Counsel (Patents), GSK

SVP Talent, Inclusion & Diversity, Bayer

Head of S&E, European BD&L, MSD

Global DEI Director, GSK

Former SVP, Head of Business Development, Amryt Pharma

Head Business Development & Licensing, Debiopharm International

VP, Head of External Innovation, Grünenthal

VP, Global Business Development & Alliances, Orion Pharma

Head of S&E, Novo Nordisk

Vice President Global Head of Business Development, Servier Monde

Director, Corporate Business Development & Strategy, Lundbeck

SVP, Global Head Business Development, GSK

VP, Venture Sciences (Europe Head), Eli Lilly

Senior Director, Search & Evaluation Neuroscience, Eli Lilly and Company

Senior Director, Venture Sciences, Eli Lilly

Corporate Vice President, Global R&D Business Development, Novo Nordisk

Director, Research Beyond Borders, Boehringer Ingelheim

Global Head, BD&L Technologies and Research Beyond Borders, Boehringer Ingelheim

SVP BD, Amgen

VP Head BD & Acquisition, Abbvie

CEO, Vivet Therapeutics

CEO, Calliditas Therapeutics

CEO, Evotec

CEO, CS Medica

CEO, OCON Healthcare

CEO, atai Life Sciences

Head of Business Development, Redx Pharma

CBO, Amphista Therapeutics

CEO, Ziphius Vaccines

CEO, Azafaros

COO, Orion Biotechnology

Head of Business Development, Azafaros

CEO, Insilico Medicine

CEO, Antion Biosciences

CEO, LoQus 23

CEO, Monument Therapeutics

Head of Technology Transfer, Medicines Patent Pool

Technology Office Lead, CEPI

Science Editor, Financial Times

CSO & Co-founder, Ochre Bio and Director, OUTbio

Co-founder and Chief Executive Officer, Apriori Bio & Origination Partner, Flagship Pioneering

Chief Business Officer, BioAge Labs

SVP, Global Market Access & Geographical Expansion, Orchard Therapeutics

CEO, AM-Pharma

CBO, Evotec

Chief Business Officer, Blueprint Medicines

CEO, Bloomsbury Genetic Therapies

CEO, Transine Therapeutics

CEO, Imophoron

Executive Director, Head of External Innovations, Lonza

VP of Licensing, Lonza

Chief Development Officer, COMPASS Pathways

CEO, Cureline

Healthcare Analyst, Trinity Delta

Managing Director, BioPharma Futures

EVP Technical Operations, Achilles Therapeutics

Managing Partner, MediStrava

Editor, Vantage

CEO, Sequana Medical

News Editor, Evaluate Vantage

Global Pharmaceuticals Correspondent, Financial Times

SVP, Global BD, Evotec

Executive Editor, In Vivo

President, Orphalan US

President, Research Manager, Cell and gene Therapy Catapult

Head of Commercial Translation, The Francis Crick Institute

CEO, Apeiron Biologics

CEO, StemMedical

Chief Business Officer, Oxurion

CEO, Roquefort Therapeutics

Chief Corporate Development and Strategy Officer, Alchemb

Managing Partner, Abingworth Life Sciences

Managing Partner, RA Capital Management

Equity Analyst, J.P. Morgan

Lead Manager, AXA Investment Managers

former CEO Ablynx and Chairman to European biotechs

Chief Investment Officer, JP Morgan Life Sciences Private Capital

Partner, Apollo Health Ventures

Managing Partner, Syncona

Partner, Forbion

Partner, Syncona

Partner, Dementia Discovery Fund – SV Health Investors

Principal, Epidarex Capital

Managing Director, M Ventures

Investment Director Life Sciences & HealthTech, Softbank Vision Fund

General Partner, TVM Capital

Partner, INKEF Capital

Principle, Novo Seeds

Principal, High-Tech Gründerfonds

Chief Talent Officer, Oxford Science Enterprises

Managing Director, Raglan Capital

Managing Partner, SV Health Investors

Principal, Monograph Capital

Director, EQT Life Sciences

Managing Director, Awen GmbH

Senior Associate, Jeito

Principal, Sound Bioventures

Principal, Forbion

Co-founder and Partner, Monograph Capital

Venture Advisor, Wellington Partners

Partner, 4BIO Capital

Head of Commercial – Pharmaceuticals, RSSL

Senior Consultant, Halloran Consulting

Head of Health Technologies, Innovate UK

Partner, Brown Rudnick

Principal - Pharmaceuticals & Biotech, Emerging Pharma Lead, ZS Associates

Principal - Portfolio & Pipeline, ZS Associates

Patent Attorney, Fish & Richardson

Vice Chair of the Global Life Sciences Practice, Latham & Watkins

Managing Director & Head of Investment Banking, Back Bay Life Science Advisors

Executive Vice President, Inizio Biotech

Director, Sterne Kessler

Managing Director, Danforth Advisors

Strategic Advisor, NDA Group

Medical Advisor, NDA Group

Partner, Coulter Partners

Head Life Sciences Markets Europe, Middle East & Africa, JLL

Corporate Development , Clarivate

Senior Investment Advisor – Biotech and Pharma, Invest Lithuania

Member, Mintz